Duality Biotherapeutics Inc. has announced a proposal for the adoption of the 2025 Share Scheme, which aims to attract, retain, and reward participants who contribute to the company's long-term growth and success. Shareholders will vote on this proposal at the upcoming extraordinary general meeting. The board recommends voting in favor of the adoption of the 2025 Share Scheme.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Duality Biotherapeutics Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251214-11954759), on December 14, 2025, and is solely responsible for the information contained therein.